Top Tweets for #ICECaP
Yesterday was an adventure. 🧊
#Icecap
Yes… I Emailed @TimHortons Years Ago With My #Beverage Idea & I’ve Continued To #Order The Same Thing For Years..
I Get #ChocolateMilk In My #IcedCoffee Or My #IceCap Instead Of Regular #Milk • Usually Delicious When Made Correctly :)
Was Told They Would..
Thanks to all who listened to #ICECAP @SiriusXMNHL throughout the #StanleyCup playoffs.
Never fails to amaze me how many reach out to say what the show means to them.
Alongside @westcoasthkyNHL, @MikeyBonora, @LucasCritelli23, @expomick, it’s a privilege!
Between-hospital variability in outcomes after cardiac arrest in a large clinical trial network. See unadjusted (A) and adjusted (B) survival to discharge from #ICECAP sites. Variability likely worse out of clinical trial sites. @ResusJournal https://t.co/ih4BXgbzS7
#ICECAP is out. This NIH-funded RCT compared different durations of cooling (12-72 hours) after cardiac arrest and found no impact of longer cooling inervals on survival or functional outcome. But there was no arm without TTM at all -- which is what many centers have now reverted to....
#curingcoma
Tonight is a night I am glad I am on the radio.
#ICECAP @SiriusXMNHL at 1am ET to put a wrap on the night in the #StanleyCupPlayoffs
How are you North Carolina after that all time classic?
@withPlanet_asa 世界遺産の大陸氷床へ。氷床とは大地を飲み込むほど巨大な「氷の蓋」のようなもので地球上で南極とここの2カ所しかありません。近くまでUTV（多目的四輪車）で行ったあとは徒歩のみ。スパイクをつけ、凍った川をロープを頼りに渡り、バキバキと響く氷塊を踏み締めて進みます。#Greenland #icecap
Our latest #ICECAP work on role of docetaxel with ADT and RT in high-risk prostate cancer, published now in @EurUrolOncol:
https://t.co/41h6DvWvh4
@DanaFarber_GU @DanaFarberNews @ChrisSweens1 @PCFnews
just pooped at school who is proud of me.... my tummy feels so much better bro @poopyballfart gets the pain #icecap
60 days of #StanleyCup playoffs. The story is always the games & it is an honor to help tell it @SiriusXMNHL
To everyone who listened along the way, myself, @westcoasthky, @MikeyBonora, @expomick & @PBerce thank you for having us on.
#ICECAP signing off. Enjoy the offseason!
Only once in NHL history has the first three games of the Stanley Cup final all gone to OT, back in 1951 (Habs-Leafs). Can Oilers-Panthers join that historical mark tonight? With an 8:20 pm ET puck drop and a post-game column to write, I'm hoping not !
Docetaxel with ADT and radiotherapy for high-risk localized #ProstateCancer: An #ICECaP IPD meta-analysis of randomized controlled trials. Presentation by @PrafulRavi1 @DanaFarber. #ASCO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/kqbT4Bnr6Q @ASCO
@PrafulRavi1 #ICECAP meta-analysis shows addition of docetaxel to RT + long-term ADT in high-risk localized #prostatecancer does not significantly improve OS and MFS, modest benefits in EFS/PCSM
#ASCO25
@OncoAlert
🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber
![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5jYxXUAA7qYj.jpg)
![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5igsWAAAiz_B.jpg)
![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5gyPWAAAlpk-.jpg)
![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5ft7WsAAACrf.jpg)
Docetaxel with ADT and radiotherapy for high-risk localized #ProstateCancer: an #ICECaP individual patient-data meta-analysis of randomized controlled trials. Presentation by @PrafulRavi1 @DanaFarber. #ASCO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/FpyBihunmW @ASCO
Dallas’ Jamie Benn has been fined $5,000, the maximum allowable under the CBA, for roughing Winnipeg’s Mark Scheifele late in Thursday night’s game.
The first #StanleyCupPlayoffs edition of #ICECAP goes with me and @MikeyBonora at 1am ET on @SiriusXMNHL
https://t.co/t3dnhQRhlb
BOOM! Twins ML (+100) CASHES for 10U!
That’s a clean sweep for VIPs — big wins, no stress.
Profits don’t sleep — why should you?
JOIN DISCORD FOR FREE USE CODE JARO7 LINK IN BIO
Discord https://t.co/PNtWkW77MR
#SportsBetting #MLBPicks #ICECAPPICKS #JARO #icecap #BettingWins
Last Seen Hashtags on Sotwe
markusvillig
Seen from United States
sislitravesti
Seen from Turkey
creampie
Seen from Netherlands
omegle
Seen from Turkey
쉬멜
Seen from Korea
設備投資
Seen from Japan
سالب_الرياض
Seen from Saudi Arabia
第1作誘拐新装版と第2作贖いは双葉文庫より絶賛発売中
Seen from United States
NewProfilePic
Seen from United States
Fun_House
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.2M followers
KATY PERRY
@katyperry
88.4M followers
Taylor Swift
@taylorswift13
82.3M followers
Lady Gaga
@ladygaga
73.8M followers
Virat Kohli
@imvkohli
71.1M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.3M followers
Neymar Jr
@neymarjr
64M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.5M followers
X
@x
60.8M followers